Crestline Management, LP - SANA BIOTECHNOLOGY INC ownership

SANA BIOTECHNOLOGY INC's ticker is SANA and the CUSIP is 799566104. A total of 124 filers reported holding SANA BIOTECHNOLOGY INC in Q3 2022. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.

Quarter-by-quarter ownership
Crestline Management, LP ownership history of SANA BIOTECHNOLOGY INC
ValueSharesWeighting
Q3 2023$13,024,965
-35.1%
3,365,6240.0%1.52%
-27.6%
Q2 2023$20,059,119
+91.0%
3,365,624
+4.8%
2.10%
+68.0%
Q1 2023$10,499,764
-21.0%
3,210,937
-4.6%
1.25%
-36.0%
Q4 2022$13,294,215
-34.2%
3,365,6240.0%1.95%
-28.6%
Q3 2022$20,194,000
-6.7%
3,365,6240.0%2.73%
-3.3%
Q2 2022$21,641,000
-18.4%
3,365,624
+4.8%
2.82%
-11.2%
Q1 2022$26,522,000
-46.6%
3,210,9370.0%3.18%
-14.4%
Q4 2021$49,705,000
-31.3%
3,210,9370.0%3.71%
-45.4%
Q3 2021$72,310,000
+14.5%
3,210,9370.0%6.80%
+24.9%
Q2 2021$63,127,0003,210,9375.44%
Other shareholders
SANA BIOTECHNOLOGY INC shareholders Q3 2022
NameSharesValueWeighting ↓
Flagship Pioneering Inc. 34,239,018$220,158,0008.29%
Crestline Management, LP 3,365,624$21,641,0002.82%
Omega Fund Management, LLC 843,750$5,425,0001.73%
Alphabet Inc. 2,812,500$18,084,0000.98%
HARVARD MANAGEMENT CO INC 468,749$3,014,0000.35%
PUBLIC SECTOR PENSION INVESTMENT BOARD 6,400,000$41,152,0000.35%
PFM Health Sciences, LP 952,733$6,126,0000.23%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 156,254$1,005,0000.20%
Viewpoint Capital Management LLC 23,545$151,0000.14%
Artal Group S.A. 400,000$2,572,0000.14%
View complete list of SANA BIOTECHNOLOGY INC shareholders